1,4-Dihydropyridine derivatives (DHPs), a major class of calcium antagonists, are in clinical use to treat angina pectoris, hypertension or subarachnoid hemorrhage. In most cases, DHPs have an asymmetric carbon at position 4 of the dihydropyridine ring and are used as racemic mixtures. As the pharmacological effects between DHP enantiomers are well known to be quantitatively or qualitatively different, 1-3 the chiral resolution techniques, especially the technique to separate isomers from biological samples, have been attracting much attention. Although capillary electrophoresis was suggested to be a useful tool for the chiral resolution of some DHPs, 4 highperformance liquid chromatography (HPLC) is most commonly used.
Two kinds of HPLC chiral stationary phases (CSPs) were reported for the chiral resolution of DHPs. One kind includes derivatized polysaccharide-based CSPs such as triphenyl carbamate 5 and tris(4-t-butylphenylcarbamate) derivatives 6 of cellulose, and xylan bis(3,5-dichlorophenylcarbamate). 7 The other includes protein-based CSPs such as α1-acid glycoprotein 8 and ovomucoid. 9 It is reported that DHPs have strong affinity for ovomucoid protein. 10 One of the advantages of proteinbased CSPs is that the aqueous solvent system can be simply used as a mobile phase. Thus, the protein-based CSPs are more convenient for biological samples.
Recently, ovomucoid from chicken egg whites (OMCHI) was further fractionated by anion-and cation-exchange chromatography. 11 The obtained fractions were composed of three OMCHI variants differing in carbohydrate composition and a new component, ovoglycoprotein (ovoglycoprotein from chicken egg whites, OGCHI). It is found that none of the OMCHI variants give any appreciable chiral recognition ability and that the chiral recognition ability of crude OMCHI comes from OGCHI, which has an average molecular weight of 29700.
The aim of present work was to evaluate the retentivity and enantioselectivity of OGCHI-based CSPs for DHPs, and to try to establish a new method for their enantioseparations. In this study, three clinically used DHPs [nilvadipine, nitrendipine, and nimodipine (structures are illustrated in Fig. 1)] were selected as the model compounds.
Experimental

Reagents and materials
Nitrendipine and nimodipine racemates were purchased from China Drug and Bioproduct Inspection Institute (Beijing, China). The racemates were directly used without any purification. (R)-(-)-and (S)-(+)-Nilvadipine were kindly donated by Fujisawa Pharmaceutical Co. (Osaka, Japan). Each racemic nilvadipine sample was made by mixing the two isomers in equal amounts.
N,N′-Disuccinimidylcarbonate (DSC) was purchased from Sigma-Aldrich Japan (Tokyo, Japan), and D-glucosamine hydrochloride was from Nacalai Tesque (Kyoto, Japan). The Ultron silica gels (5 µm diameter, 12 nm pore size, 300 m 2 g -1 ) were obtained from Shinwa Chemical Industries (Kyoto, Japan). SP Sepharose FF and Sephadex G-25 (fine) were obtained from Amersham Pharmacia Biotech (Tokyo, Japan).
Ethanol, methanol, acetonitrile and 2-propanol obtained from Wako Pure Chemical Industries (Osaka, Japan) were distilled before use. Other solvents and reagents were used without further purification.
Water, purified by using a Nanopure II unit (Barnstead, Boston, MA, USA), was used for the preparation of the eluent and the sample solution.
Isolation and purification of OGCHI from OMCHI and preparation of OGCHI-based CSP
Crude OMCHI was isolated by the modified ethanol precipitation method. 12 To get OGCHI, the obtained OMCHI was further purified on SP sepharose FF and Sephadex G-25 (fine) columns as reported previously. 11 A reversed-phase chromatography 11 was employed to determine the purity of the isolated OGCHI and the amounts of OGCHI bound to activated silica gels. The purity of OGCHI was estimated to be 99%, calculated from peak area.
The preparation of OGCHI-based CSP was accomplished according to the following procedure. First, Ultron silica gel (5 g) was dried in vacuo over P2O5 at 150˚C for 6 h and the dry silica gel was added to 120 mL of dry toluene. The mixture was heated to reflux until all of the water could be removed as an azeotrope into a Dean-Stark-type trap. 3-Aminopropyltriethoxysilane, corresponding to 10 µmol m -2 of the specific surface area, was added and the mixture was reacted for 8 h. The reaction mixture was cooled to room temperature, filtered and washed with toluene and methanol. The isolated silica gels were dried in vacuo over P2O5 at 60˚C for 2 h. Second, the synthesized aminopropyl silica gels were activated by DSC. A 5 g amount of the gel was slurried in 70 mL of anhydrous acetonitrile and reacted with 5 g of DSC for 23 h at 30˚C. The reaction mixture was filtered and washed with acetonitrile, water, methanol and dichloromethane, respectively. The obtained DSC-activated aminopropyl-silica gels were dried in P2O5 at 80˚C for 1 h. Third, OGCHI was bound to DSCactivated aminopropyl-silica gels. A 1 g amount of the activated silica gel was slurried in 20 mM phosphate buffer (pH 6.8). To the mixture, 80 mg of OGCHI dissolved in 20 mL of the same buffer was added gradually at room temperature for 1 h by adjusting the pH to 6.6, and the mixture was further stirred for 15 h at 30˚C. Fourth, the reaction mixture was washed with water and dissolved in 20 mL of a blocking solution that was containing 300 mM D-glucosamine. Then the mixtures were filtered and washed with water and methanol. To the DSCactivated silica gels, 89.7% of OGCHI was bound; this was determined by subtracting the amount of protein measured in the wash solution after reaction from the amount initially added to the reaction.
The obtained materials were packed into a 2.0 mm i.d. × 100 mm stainless-steel column by the slurry packing method using ethanol-water (10:90, v/v) as the slurry and packing solvent.
Chromatography
The HPLC system is composed of a Jasco 880-PU pump, a 875-UV/VIS detector (both from Jasco, Tokyo, Japan), a Rheodyne 7125 injector with a 5-µL loop and a C-R6A integrator (Shimadzu, Kyoto, Japan). The flow rate was maintained at 0.2 mL min -1 . Detection was performed at 236 nm. The column temperature was set and controlled at 25˚C unless otherwise stated by a temperature-regulating water bath (Thermo Minder Lt-100, Taitec, Saitama, Japan). The eluent was prepared using sodium dihydrogenphosphate-disodium hydrogenphosphate (unless otherwise stated) and an organic modifier. The eluent used is specified in each table text and figure legend. All mobile phases were filtered through a 0.45 µm membrane and degassed by ultrasonication before use.
Retention factor (k), enantioseparation factor (α) and resolution (Rs) of a racemate were calculated according to the procedures described previously. 13 
Sample preparation
As the DHP samples are practically water insoluble and unstable to light, the samples were first dissolved in methanol to a concentration of about 0.1 mg mL -1 and then diluted to a concentration of about 0.02 mg mL -1 with water before use. A 5-µL aliquot of the sample solution was loaded onto the column.
Results and Discussion
Effect of type and content of organic modifier
Four generally used organic modifiers for protein-based CSPs were selected to examine the resolution of DHP enantiomers. Table 1 shows the effects of the type of organic modifier on the retention factor, enantioseparation factor and resolution of DHPs, where a mixture of 50 mM sodium phosphate buffer solution (pH 5.1) and 30% methanol, 20% ethanol, 12.5% 2-prapanol or 15% acetonitrile, is used as the eluent. Nilvadipine and nitrendipine racemates can be completely separated with Rs larger than 2.05 when the above concentration of ethanol, methanol or 2-prapanol is chosen. For nimodipine racemates, better resolution, with Rs 1.34, was achieved using 20% ethanol. Nimodipine can not be enantioseparated when 15% acetonitrile is employed as the organic modifier. Further decreasing acetonitrile concentration could increase retentions drastically but the chiral resolution was not attained. The typical separations of DHP enantiomers using 20% ethanol as the organic modifier are shown in Fig. 2 .
The effect of ethanol concentration from 20 to 25% on DHP ; detection, 236 nm; loaded amount, 0.1 µg. Eluent, 50 mM sodium dihydorgenphosphate and disodium hydrogenphosphate buffer (pH 5.1), including 20% ethanol, 30% methanol, 15% acetonitrile, or 12.5% 2-propanol. k1 is the retention factor of first-eluted enantiomer.
is the enantioseparation factor and Rs is the resolution. α α α α α resolution was examined by keeping sodium phosphate buffer concentration at 50 mM (pH 5.1) and column temperature at 25˚C. The retention and resolution are sharply reduced with an increase of ethanol concentration. This result, similar to the characteristics observed with the α1-acid glycoprotein-8 and ovomucoid-based 9 CSPs, suggests that the concentration of ethanol is an important factor in retention and resolution, and that the hydrophobic interactions could play an important role in the separation process on the OGCHI-based CSP. Table 2 shows the effect of eluent pH on the retention factor, enantioseparation factor and resolution of DHPs. For nilvadipine, the retention factor, enantioseparation factor and resolution increased moderately with an increase in eluent pH. For nitrendipine and nimodipine, those parameters were not so much affected. In our study, the isoelectric point (pI) of OGCHI was proven to be 4.37 -4.51. 14 Around pI, the protein is almost uncharged, and with an increase of the eluent pH, the proportion of negative charged protein could be increased. However, the retentivity and enantioselectivity of DHPs tested were not so much affected despite eluent pH changes. This result suggests that the hydrophobic interactions may mainly work for the resolution of DHPs on OGCHI-based CSP as described above. Table 3 shows the effect of sodium phosphate buffer concentration on the retention factor, enantioseparation factor and resolution of DHPs. The phosphate buffer pH was set at 5.1 and the ethanol content was 20%. It can be seen that the retention factors of DHPs decreased slightly with an increase in the phosphate buffer concentration from 20 to 100 mM. The highest enantioseparation factors were obtained at 20 mM for nilvadipine and nitrendipine. Table 4 shows the effects of column temperature on the retention factor, enantioseparation factor and resolution of DHPs, where 50 mM sodium phosphate buffer (pH 5.1) containing 20% ethanol is used as an eluent. The retention factor, enantioseparation factor, and resolution of all DHPs tested increased with a decrease of column temperature. The relationship between retention and temperature could be described according to the van't Hoff equation:
Effect of eluent pH
Effect of buffer concentration
Effect of column temperature
where ∆H˚ and ∆S˚, respectively, are the differences in enthalpy and entropy of the solute in the two phases, R is the ideal gas constant, and φ is the solute phase ratio. The van't Hoff equation can be rewritten to describe the chiral resolution process:
The calculated parameters are listed in Table 5 . Thus, the chiral resolution process is enthalpically driven. The correlation coefficients of the van't Hoff plots are all above 0.99. Since the parameter change of -∆H˚/R or ∆S˚/R with changes in temperatures is the evidence of protein conformation change, 15 the OGCHI protein conformation change did not occur or 899 ANALYTICAL SCIENCES JULY 2001, VOL. 17 Table 1 occurred in a minor way during the column temperature range tested.
In conclusion, the results obtained above indicate that the CSP based on OGCHI exhibited high enantioselectivity to DHPs, nilvadipine, nitrendipine and nimodipine. The retentivity and enantioselectivity of DHPs were optimized by changing the type and content of organic modifier, and column temperature. The resolution was enthalpically driven and the hydrophobic interactions could play an important role in resolution. The application of this method for chiral resolution of DHPs in biological samples is under study. Table 5 The thermodynamic parameters for the separation of DHPs on OGCHI column a a. The column temperature ranges from 10˚C to 40˚C. Other HPLC conditions as in Table 4 . Subscripts 1 and 2 mean the first-eluted and the second-eluted enantiomers, respectively. ∆H˚ and ∆S˚, respectively, are the differences in enthalpy and entropy of the solute in the two phases, R is the ideal gas constant, and is the solute phase ratio.
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